NCT01751932View on ClinicalTrials.gov

Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring Systems

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Diabetes Mellitus
Interventions
DEVICE

CGM Monitoring

All patients will be fitted with the two study CGM systems. Paradigm Veo will be configured to use the CGM part only if another pump is used.

Trial Locations (1)

1105AZ

Academic Medical Center, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT01751932 - Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring Systems | Biotech Hunter | Biotech Hunter